Literature DB >> 17252230

Comparison of clinical and post-mortem findings in intensive care unit patients.

Calliope Maris1, Benoît Martin, Jacques Creteur, Myriam Remmelink, Michael Piagnerelli, Isabelle Salmon, Jean-Louis Vincent, Pieter Demetter.   

Abstract

The autopsy has long been regarded as an important tool for clinical confrontation, education and quality assurance. The aims of this study were to examine the correlation between the clinical diagnosis and autopsy findings in adult patients who died in an intensive care unit (ICU) and to identify the types of errors in diagnosis to improve quality of care. Autopsies from 289 patients who died in the ICU during a 2-year period were studied. Post-mortem examination revealed unexpected findings in 61 patients (21%) including malignancy, pulmonary embolism, aspergillosis, myocardial or mesenteric infarction and unsuspected bacterial, viral or fungal infection. These unexpected findings were classified as Goldman class I errors in 17 (6%), class II in 38 (13%) and class III in six (2%) cases. Although the incidence of unexpected findings with clinical significance was low, post-mortem examination remains a valuable source of pertinent information that may improve the management of ICU patients.

Entities:  

Mesh:

Year:  2007        PMID: 17252230     DOI: 10.1007/s00428-006-0364-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  52 in total

Review 1.  Clinical diagnosis and the function of necropsy.

Authors:  J H Baron
Journal:  J R Soc Med       Date:  2000-09       Impact factor: 5.344

Review 2.  Maximizing the benefits of autopsy for clinicians and families. What needs to be done.

Authors:  S J McPhee
Journal:  Arch Pathol Lab Med       Date:  1996-08       Impact factor: 5.534

3.  Does it matter who requests necropsies? Prospective study of effect of clinical audit on rate of requests.

Authors:  I S Kamal; D R Forsyth; J R Jones
Journal:  BMJ       Date:  1997-06-14

4.  Autopsy as quality assurance in the intensive care unit.

Authors:  P Fernandez-Segoviano; A Lázaro; A Esteban; J M Rubio; J R Iruretagoyena
Journal:  Crit Care Med       Date:  1988-07       Impact factor: 7.598

5.  Diagnostic advances v the value of the autopsy. 1912-1980.

Authors:  L Goldman
Journal:  Arch Pathol Lab Med       Date:  1984-06       Impact factor: 5.534

6.  A symposium on the autopsy.

Authors:  R Yesner; M J Robinson; L Goldman; C M Reichert; L Engel
Journal:  Pathol Annu       Date:  1985

7.  Autopsy: quality assurance in the ICU.

Authors:  A L Gut; A L Ferreira; M R Montenegro
Journal:  Intensive Care Med       Date:  1999-04       Impact factor: 17.440

8.  Do autopsies of critically ill patients reveal important findings that were clinically undetected?

Authors:  S A Blosser; H E Zimmerman; J L Stauffer
Journal:  Crit Care Med       Date:  1998-08       Impact factor: 7.598

9.  Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect?

Authors:  E C Burton; D A Troxclair; W P Newman
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

10.  Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study.

Authors:  Gavin D Perkins; Danny F McAuley; Sarah Davies; Fang Gao
Journal:  Crit Care       Date:  2003-09-05       Impact factor: 9.097

View more
  14 in total

1.  Post mortem scientific sampling and the search for causes of death in intensive care: what information should be given and what consent should be obtained?

Authors:  J P Rigaud; J P Quenot; M Borel; I Plu; C Hervé; G Moutel
Journal:  J Med Ethics       Date:  2010-12-24       Impact factor: 2.903

2.  [Evaluation of the clinical utility of autopsy: an investigation at the Institute of Pathology, University Hospital of Leipzig].

Authors:  K Nestler; T Gradistanac; C Wittekind
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

3.  Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.

Authors:  Francesco G De Rosa; Pierpaolo Terragni; Daniela Pasero; Anna C Trompeo; Rosario Urbino; Anna Barbui; Giovanni Di Perri; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2009-06-16       Impact factor: 17.440

4.  Clinical or postmortem? The importance of the autopsy; a retrospective study.

Authors:  Mariana Costache; Anca Mihaela Lazaroiu; Andreea Contolenco; Diana Costache; Simion George; Maria Sajin; Oana Maria Patrascu
Journal:  Maedica (Buchar)       Date:  2014-09

Review 5.  [Autopsy-a procedure of medical history?].

Authors:  K Petros; C Wittekind
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-02-17       Impact factor: 0.840

Review 6.  Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Authors:  Marco Falcone; Ercole Concia; Ido Iori; Giuliana Lo Cascio; Antonino Mazzone; Federico Pea; Francesco Violi; Mario Venditti
Journal:  Intern Emerg Med       Date:  2014-05-29       Impact factor: 3.397

Review 7.  Current challenges in the microbiological diagnosis of invasive aspergillosis.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

8.  Clinico-pathological discrepancies in a general university hospital in São Paulo, Brazil.

Authors:  Fabiana Kotovicz; Thais Mauad; Paulo H N Saldiva
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

9.  Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.

Authors:  Sabina Berezowska; Andreas Schmid; Tereza Losmanová; Mafalda Trippel; Annika Blank; Yara Banz; Stephan M Jakob; Rupert Langer
Journal:  Diagnostics (Basel)       Date:  2021-05-18

10.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project).

Authors:  M T Montagna; G Caggiano; G Lovero; O De Giglio; C Coretti; T Cuna; R Iatta; M Giglio; L Dalfino; F Bruno; F Puntillo
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.